Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J.
Mahaffy, Chief Executive Officer and President, will present at the Bank
of America Merrill Lynch Healthcare Conference 2019 on Tuesday, May 14,
2019 at 2:20 PM Pacific Time. The conference will be held at the Encore
Hotel in Las Vegas, Nevada.
A live webcast of the presentation can be accessed through the investor
relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be
available on the Company’s website for 30 days.
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, for those
indications that require them, diagnostic tools intended to direct a
compound in development to the population that is most likely to benefit
from its use. Clovis Oncology is headquartered in Boulder, Colorado;
please visit www.clovisoncology.com
for more information, including additional office locations in the U.S.
and Europe.
Contacts
Anna Sussman
303.625.5022
asussman@clovisoncology.com
Breanna
Burkart
303.625.5023
bburkart@clovisoncology.com
